The Real Planning Challenges in Pharma & MedTech

In this webinar, two experienced supply chain leaders will share how planning really works in pharma and medtech environments, from planning for product launches to inventory risk, regulation, and the evolving role of planners and IBP.

The discussion will focus on lessons learned across different roles and maturity levels, rather than theory, benchmarks, or idealized frameworks.

Meet the panelists

Michael Altman is Head of End-to-End Self Care Supply Chain at Kenvue (formerly Johnson & Johnson Consumer Health). With more than 30 years of experience across consumer health and pharmaceuticals, he has led end-to-end supply chains, demand and supply planning, and new product strategy at companies such as Novartis and Teva.

Zoltan Solyom is Supply Chain Director at Coloplast. With a background in market supply chain, new product introductions, and end-to-end operations across pharma and medtech, he focuses on translating planning decisions into execution while balancing risk, compliance, and operational performance.

What we’ll cover

Planning under uncertainty
Growth expectations, product launches, limited history, and volatile demand patterns in pharma and medtech

Inventory decisions in regulated environments
Service levels, shelf life, risk mitigation, and balancing excess vs. availability

IBP, systems, and the evolving planner role
What IBP enables in pharma/medtech, the reality of Excel alongside enterprise systems, and the potential role of AI  

Q&A

Who this session is for

This webinar is designed for supply chain leaders, planning managers, and S&OP / IBP owners in pharma, life sciences, and medtech companies.

If you are dealing with demand uncertainty, launches, inventory risk, or modernizing planning processes in regulated environments, this session offers practical perspectives from peers facing similar challenges.